|23.78||+1.07 / +4.71%|
As of 3:59pm ET
|23.80||+0.02 / +0.08%|
The 6 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 43.00, with a high estimate of 48.00 and a low estimate of 24.00. The median estimate represents a +80.82% increase from the last price of 23.78.
The current consensus among 7 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.